The radiation response of androgen-refractory prostate cancer cell line C4-2 derived from androgen-sensitive cell line LNCaP

Bang Xiang Xie, Hui Zhang, Lan Yu, Jian Wang, Bo Pang, Rui Qin Wu, Xiao Long Qian, Shan Hu Li, Qing Guo Shi, Le Le Wang, Jian Guang Zhou

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Radiation therapy is a relatively effective therapeutic method for localized prostate cancer (PCa) patients. However, radioresistance occurs in nearly 30% of patients treated with potentially curative doses. Therapeutic synergy between radiotherapy and androgen ablation treatment provides a promising strategy for improving the clinical outcome. Accordingly, the androgen deprivation-induced signaling pathway may also mediate radiosensitivity in PCa cells. The C4-2 cell line was derived from the androgen-sensitive LNCaP parent line under androgen-depleted condition and had acquired androgen-refractory characteristics. In our study, the response to radiation was evaluated in both LNCaP and C4-2. Results showed that C4-2 cells were more likely to survive from irradiation and appeared more aggressive in their resistance to radiation treatment compared with LNCaP, as measured by clonogenic assays and cell viability and cell cycle analyses. Gene expression analyses revealed that a set of genes involved in cell cycle arrest and DNA repair were differentially regulated in LNCaP and C4-2 in response to radiation, which was also consistent with the radiation-resistant property observed in C4-2 cells. These results strongly suggested that the radiation-resistant property may develop with progression of PCa to androgen-independent status. Not only can the LNCaP and C4-2 PCa progression model be applied for investigating androgen-refractory progression, but it can also be used to explore the development of radiation resistance in PCa.

Original languageEnglish (US)
Pages (from-to)405-414
Number of pages10
JournalAsian Journal of Andrology
Volume12
Issue number3
DOIs
StatePublished - May 1 2010
Externally publishedYes

Fingerprint

Androgens
Prostatic Neoplasms
Radiation
Cell Line
Radiotherapy
Radiation Tolerance
Therapeutics
Cell Cycle Checkpoints
DNA Repair
Cell Survival
Cell Cycle
Gene Expression
Genes

Keywords

  • C4-2
  • LNCaP
  • Prostate cancer
  • Radiation response

ASJC Scopus subject areas

  • Urology

Cite this

The radiation response of androgen-refractory prostate cancer cell line C4-2 derived from androgen-sensitive cell line LNCaP. / Xie, Bang Xiang; Zhang, Hui; Yu, Lan; Wang, Jian; Pang, Bo; Wu, Rui Qin; Qian, Xiao Long; Li, Shan Hu; Shi, Qing Guo; Wang, Le Le; Zhou, Jian Guang.

In: Asian Journal of Andrology, Vol. 12, No. 3, 01.05.2010, p. 405-414.

Research output: Contribution to journalArticle

Xie, BX, Zhang, H, Yu, L, Wang, J, Pang, B, Wu, RQ, Qian, XL, Li, SH, Shi, QG, Wang, LL & Zhou, JG 2010, 'The radiation response of androgen-refractory prostate cancer cell line C4-2 derived from androgen-sensitive cell line LNCaP', Asian Journal of Andrology, vol. 12, no. 3, pp. 405-414. https://doi.org/10.1038/aja.2009.91
Xie, Bang Xiang ; Zhang, Hui ; Yu, Lan ; Wang, Jian ; Pang, Bo ; Wu, Rui Qin ; Qian, Xiao Long ; Li, Shan Hu ; Shi, Qing Guo ; Wang, Le Le ; Zhou, Jian Guang. / The radiation response of androgen-refractory prostate cancer cell line C4-2 derived from androgen-sensitive cell line LNCaP. In: Asian Journal of Andrology. 2010 ; Vol. 12, No. 3. pp. 405-414.
@article{365e30058ec2447aa767a8fdcfe97bf6,
title = "The radiation response of androgen-refractory prostate cancer cell line C4-2 derived from androgen-sensitive cell line LNCaP",
abstract = "Radiation therapy is a relatively effective therapeutic method for localized prostate cancer (PCa) patients. However, radioresistance occurs in nearly 30{\%} of patients treated with potentially curative doses. Therapeutic synergy between radiotherapy and androgen ablation treatment provides a promising strategy for improving the clinical outcome. Accordingly, the androgen deprivation-induced signaling pathway may also mediate radiosensitivity in PCa cells. The C4-2 cell line was derived from the androgen-sensitive LNCaP parent line under androgen-depleted condition and had acquired androgen-refractory characteristics. In our study, the response to radiation was evaluated in both LNCaP and C4-2. Results showed that C4-2 cells were more likely to survive from irradiation and appeared more aggressive in their resistance to radiation treatment compared with LNCaP, as measured by clonogenic assays and cell viability and cell cycle analyses. Gene expression analyses revealed that a set of genes involved in cell cycle arrest and DNA repair were differentially regulated in LNCaP and C4-2 in response to radiation, which was also consistent with the radiation-resistant property observed in C4-2 cells. These results strongly suggested that the radiation-resistant property may develop with progression of PCa to androgen-independent status. Not only can the LNCaP and C4-2 PCa progression model be applied for investigating androgen-refractory progression, but it can also be used to explore the development of radiation resistance in PCa.",
keywords = "C4-2, LNCaP, Prostate cancer, Radiation response",
author = "Xie, {Bang Xiang} and Hui Zhang and Lan Yu and Jian Wang and Bo Pang and Wu, {Rui Qin} and Qian, {Xiao Long} and Li, {Shan Hu} and Shi, {Qing Guo} and Wang, {Le Le} and Zhou, {Jian Guang}",
year = "2010",
month = "5",
day = "1",
doi = "10.1038/aja.2009.91",
language = "English (US)",
volume = "12",
pages = "405--414",
journal = "Asian Journal of Andrology",
issn = "1008-682X",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - The radiation response of androgen-refractory prostate cancer cell line C4-2 derived from androgen-sensitive cell line LNCaP

AU - Xie, Bang Xiang

AU - Zhang, Hui

AU - Yu, Lan

AU - Wang, Jian

AU - Pang, Bo

AU - Wu, Rui Qin

AU - Qian, Xiao Long

AU - Li, Shan Hu

AU - Shi, Qing Guo

AU - Wang, Le Le

AU - Zhou, Jian Guang

PY - 2010/5/1

Y1 - 2010/5/1

N2 - Radiation therapy is a relatively effective therapeutic method for localized prostate cancer (PCa) patients. However, radioresistance occurs in nearly 30% of patients treated with potentially curative doses. Therapeutic synergy between radiotherapy and androgen ablation treatment provides a promising strategy for improving the clinical outcome. Accordingly, the androgen deprivation-induced signaling pathway may also mediate radiosensitivity in PCa cells. The C4-2 cell line was derived from the androgen-sensitive LNCaP parent line under androgen-depleted condition and had acquired androgen-refractory characteristics. In our study, the response to radiation was evaluated in both LNCaP and C4-2. Results showed that C4-2 cells were more likely to survive from irradiation and appeared more aggressive in their resistance to radiation treatment compared with LNCaP, as measured by clonogenic assays and cell viability and cell cycle analyses. Gene expression analyses revealed that a set of genes involved in cell cycle arrest and DNA repair were differentially regulated in LNCaP and C4-2 in response to radiation, which was also consistent with the radiation-resistant property observed in C4-2 cells. These results strongly suggested that the radiation-resistant property may develop with progression of PCa to androgen-independent status. Not only can the LNCaP and C4-2 PCa progression model be applied for investigating androgen-refractory progression, but it can also be used to explore the development of radiation resistance in PCa.

AB - Radiation therapy is a relatively effective therapeutic method for localized prostate cancer (PCa) patients. However, radioresistance occurs in nearly 30% of patients treated with potentially curative doses. Therapeutic synergy between radiotherapy and androgen ablation treatment provides a promising strategy for improving the clinical outcome. Accordingly, the androgen deprivation-induced signaling pathway may also mediate radiosensitivity in PCa cells. The C4-2 cell line was derived from the androgen-sensitive LNCaP parent line under androgen-depleted condition and had acquired androgen-refractory characteristics. In our study, the response to radiation was evaluated in both LNCaP and C4-2. Results showed that C4-2 cells were more likely to survive from irradiation and appeared more aggressive in their resistance to radiation treatment compared with LNCaP, as measured by clonogenic assays and cell viability and cell cycle analyses. Gene expression analyses revealed that a set of genes involved in cell cycle arrest and DNA repair were differentially regulated in LNCaP and C4-2 in response to radiation, which was also consistent with the radiation-resistant property observed in C4-2 cells. These results strongly suggested that the radiation-resistant property may develop with progression of PCa to androgen-independent status. Not only can the LNCaP and C4-2 PCa progression model be applied for investigating androgen-refractory progression, but it can also be used to explore the development of radiation resistance in PCa.

KW - C4-2

KW - LNCaP

KW - Prostate cancer

KW - Radiation response

UR - http://www.scopus.com/inward/record.url?scp=77952042528&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952042528&partnerID=8YFLogxK

U2 - 10.1038/aja.2009.91

DO - 10.1038/aja.2009.91

M3 - Article

C2 - 20118949

AN - SCOPUS:77952042528

VL - 12

SP - 405

EP - 414

JO - Asian Journal of Andrology

JF - Asian Journal of Andrology

SN - 1008-682X

IS - 3

ER -